News

May 6th.October 17th. We are looking forward to the Natural Health Expo in Cambridge later this month. I'd especially like to welcome Roger (Dr Hug) and Maureen Kennerly as stall holders in Cambridge.

They've been so busy running their health shop 'Whangamata Wellness' over recent years they've been unable to grace us with their presence. They will be showing their exciting range of creams which they've developed for more than 10 years, for healing small wounds, for body stress and pain, for skin conditions, rheumatism and much more. They are a particularly gifted couple in body work, nutrition and readings. Great all-round practitioners.

 

 

 

 

 

October 17th. I'm really delighted to introduce Philip Woolerton, seminar speaker, 12 midday, Saturday 27th. His topic:  Last Rites and Natural Endings (Eco Funerals)

.Conventional funeral practices have a very high environmental impact. Philip discusses the key components of green funerals.

Many people who have environmental sympathies wish to leave this world in the way they have tried to live in it. The growing number of products and services can help them to do just that.

October 14th.

Have you had a cough that has gone on and on for weeks? This could be a much better solution!

South African pharamicist, Paul Bosman, presents a new product, Flugon and Sinulex.. Paul's seminar is 11am Saturday 17th

  For hundreds of years the Zulu, Basuto, Xhosa and Mfengi cultures have used Pelargonium sidoides as a curative for coughs, upper respiratory tract irritations and gastrointestinal concerns. Today, with the advantages of modern science and clinical research, we are able to better understand what makes this traditional remedy work so effectively

Works Differently: While most other cough, cold and sinus medications simply mask outward symptoms, the mechanisms and actions of Pelargonium sidoides actually support faster recovery.

Shortens Duration and Reduces Severity: Clinical trials show that Pelargonium sidoides shortens the duration and reduces the severity of upper respiratory irritations.

High Satisfaction: In a physician assessment of adults and children suffering from common cold, chest and throat irritations, was rated effective in nearly 90% of cases!.(See the bottom of this page for more infomation and clinical studies)

September 12th

 

New exhibitors:

Jill Brooks, author of 'An Apple a Day' has just registered as an exhibitor. Her new inspirational book is  .. well ... inspirational! This is a tool for staying on track with new health resolutions. Stand strong, kia kaha, allow your heart strengths to motivate you.

Also, Gini Collin of Earth Energies NZ is lauching a new crystal range at the expo. These are significant for this time in our evolution in Aotearoa, aiding the transformation of our carbon-based cells into crystalline-based cells. These 100 light crystals are connected to the giant selenite caves in Mexico. Conven

August 31st.

Allan Smith, whose life was saved in 2009 by intravenous Vitamin C at Auckland hospital will speak at the Natural Health Expo in October.

This Saturday, Sept 15th he will be protesting at Auckland Hospital- for turning its  back on this life-saving treatment.

Smith was featured on two segments on '60 minutes' with his surprising story of near fatal illness with Swine Flu and pneumonia, and the willingness of Auckland Hospital to 'pull the plug' on him - kill him- rather than give him Vitamin C. Vitamin C, especially in high doeses, has been a well-known and scientifically accepted anti-viral for many years, and yet Auckland hospital initially refused to administer it, falsely claiming that they had tried everything to no avail. When the hospital, under pressure from the family, finally and RELUCTANTLY administered Vitamin C, Smith began to show a dramatic improvement within days. Within a few short weeks he was well again.

Unfortunately, Auckland Hospital and many other NZ hospitals seem to have learned nothing from the experience and continue to REFUSE  to administer Vitamin C to patients presenting with acute viral illnesses such as the flu. Some people reportedly have died as a result of this refusal.

For further information, contact Allan Smith: 07 873 572 or 027 472 2975

February 16 2012 dates confirmed for Hamilton.;Sat Sun Oct 28 for info if you are interested in having a stall please click here

 
Pelargonium sidoides has been successfully used for the treatment of:

General: Pelargonium sidoides occurs throughout the eastern Cape, Lesotho, Free State and southern and south-western Gauteng in the Republic of South Africa.

Pelargonium sidoides is called by Kalwerbossie or Rabassamin South Africa. However, the name Umckaloabo is most commonly known and originates from the Zulu language "heavy cough".

The Englishman Charles Stevens already acknowledged the successful treatment of tuberculosis with pelargonium extract in the early 1920’s. Extracts of the root have been available in German pharmacies since 1983 without prescription and have found widespread usage against infections of the sinus, throat and respiratory tract.

The traditional use of Pelargonium sidoides for coughs and chest troubles may be explained by the presence of essential oils. It has not yet been established which ingredients contribute to its antibacterial properties.

Extracts of Pelargonium sidoides have clear antibacterial characteristics against Streptococci, Staphylococci and Bacillus cereus.

Pelargonium sidoides is also rich in phytochemicals, vitamins, minerals and amino acids that enhance the body’s functioning and protects it against diseases. Treatment with Pelargonium sidoides rapidly improves the typical symptoms associated with infections such as cough, fever, sore throat, fatigue and weakness.

How a Zulu remedy became a best-selling new medicine: With phenomenal growth, it's gone from being an obscure herbal remedy to become one of Germany's top new medicines. In the past two years sales have jumped over 700%--growing faster than any other brand. It's success is attributed to impressive clinical results, high consumer satisfaction and a fascinating history.

A Fascinating Story: In 1897, an Englishman named Charles Stevens went to South Africa hoping to cure himself of tuberculosis. He consulted with a Basuto tribal healer who gave him a decoction of a local medicinal plant. Fully recovered, Charles Stevens returned to England with his mysterious remedy--which became popular throughout Europe as "Steven's Consumption Cure". In 1920, a former missionary doctor, Adrien Sechehaye, learned of Steven's cure. During the next nine years he treated over 800 patients in Switzerland with a homeopathic preparation of the medicine. In 1929 he published the medical case studies.

But with the introduction of synthetic tuberculosis drugs, Steven’s remedy became largely forgotten in Western medicine--until its recent "rediscovery" by European researchers.

What the Basuto healer gave Charles Stevens was a traditional remedy made from the roots of Pelargonium sidoides - a species of geranium unique to South Africa. Among the Zulu, the medicine was described as "umKhulkane' (denoting respiratory infection) + 'uHlabo' (roughly meaning chest pain).

Works Differently: While most other cough, cold and sinus medications simply mask outward symptoms, the mechanisms and actions of Pelargonium sidoides actually support faster recovery.

Shortens Duration and Reduces Severity: Clinical trials show that Pelargonium sidoides shortens the duration and reduces the severity of upper respiratory irritations.

High Satisfaction: In a physician assessment of adults and children suffering from common cold, chest and throat irritations, was rated effective in nearly 90% of cases!

Its success is attributed to impressive clinical results, high consumer satisfaction and a fascinating history that has its roots in South African heritage and culture

Efficacy of extract of Pelargonium sidoides in children with acute non-group A beta-haemolytic streptococcus tonsillopharyngitis: a randomized, double-blind, placebo-controlled trial.
Bereznoy VV, Riley DS, Wassmer G, Heger M.
Paediatric Department II, Academy for Continuing Medical Education, Kiev, Ukraine.
Background: Clinical trial data suggest that antibiotics are not indicated for the treatment of acute non-group A beta haemolytic strep (non-GABHS) tonsillopharyngitis. Nevertheless patients are symptomatic and effective alternatives for its treatment are needed that have been evaluated in clinical trials.
Objective: To confirm that treatment with an extract of Pelargonium sidoides (EPs 7630) is superior to placebo for the treatment of non-GABHS tonsillopharyngitis in children.
Design: Randomised, double-blind, placebo-controlled trial.
Setting: Six study sites in 4 paediatric and ENT primary care outpatient clinics.
Patients: One hundred forty-three children aged 6-10 years with non-GABHS tonsillopharyngitis present < or = 48 h, a negative rapid strep screen, a Tonsillopharyngitis Severity Score (TSS) > or = 8 points, and informed consent.
Intervention: EPs 7630 or placebo (20 drops tid) for 6 days.
Measurement: The primary outcome criterion was the decrease of the TSS from baseline (day 0) to day 4. RESULTS: The decrease of the TSS from baseline (day 0) to day 4 was 7.1 +/- 2.1 points under EPs 7630 (n = 73), and 2.5 +/- 3.6 points under placebo (n = 70). The covariate adjusted decrease was 7.0 +/- 2.4 points under EPs 7630, and 2.9 +/- 2.4 points under placebo. The 95% RCI for the difference between the groups was [2.7; 4.9] demonstrating a significant difference in efficacy of EPs 7630 compared to placebo (P < 0.0001). Adverse events (AEs) occurred in 15/143 patients (EPs 7630: 4/73 patient, placebo: 44/70) and were not related to the investigational medication.
Conclusions: EPs 7630 was superior compared to placebo for the treatment of acute non-GABHS tonsillopharyngitis in children. Treatment with EPs 7630 reduced the severity of symptoms and shortened the duration of illness by at least 2 days.

Immunomodulatory principles of Pelargonium sidoides.
Kayser O, Kolodziej H, Kiderlen AF.
Institut fur Pharmazie,Pharmazeutische Biologie, Freie Universität Berlin, Germany.
Extracts and isolated constituents (coumarins and phenols) of Pelargonium sidoides DC, a plant species used in folk medicine by the Southern African native population, were evaluated for their effects on nonspecific immune functions.
Although this herbal medicine is also successfully employed in modern phytotherapy in Europe to cure infectious diseases of the respiratory tract, the scientific basis of its remedial effects is still unclear. Thus, functional bioassays including an in vitro model for intracellular infection with Leishmania parasites, an extracellular Leishmania growth assay, a fibroblast-virus protection assay (IFN activity), a fibroblast-lysis assay (TNF activity) and a biochemical assay for inorganic nitric oxides (iNO) were employed.
None of the test samples revealed significant activity against extracellular, promastigote Leishmania donovani, the causative agent of human visceral leishmaniasis.
In contrast, apart from the coumarin samples, all the Pelargonium extracts (EC(50) <0.1-3.3 microg/mL), gallic acid (EC(50) 4.4 microg/mL) and its methyl ester (EC(50) 12.5 microg/mL) significantly reduced the intracellular survival of L. donovani amastigotes within murine macrophages.
These data indicate that the samples acted indirectly on Leishmania parasites, possibly by activating leishmanicidal macrophage functions. Macrophage activation was confirmed by detection of tumour necrosis factor (TNF-alpha) and inorganic nitric oxides (iNO) in supernatants of sample-treated macrophage cultures. Synthesis of iNO is a well-known effector mechanism of macrophages against microorganisms such as Leishmania. Interestingly, blocking iNO-synthase with L-NMMA had no substantial effect on sample-induced intracellular Leishmania kill.

From bioassay-guided fractionation, gallic acid and its methyl ester present in large amounts in P. sidoides and in its active extracts, were identified as the prominent immunomodulatory principle for this herbal medicine.
The results, when taken together with recent reported antibacterial activity, provide a rational basis for both the traditional and the present utilization of P. sidoides in the claimed conditions.
Copyright 2001 John Wiley & Sons, Ltd.